NASDAQ:ALGN • US0162551016
The current stock price of ALGN is 164.23 USD. Today ALGN is down by -1.61%. In the past month the price decreased by -15.49%. In the past year, price increased by 0.43%.
ChartMill assigns a technical rating of 3 / 10 to ALGN. When comparing the yearly performance of all stocks, ALGN turns out to be only a medium performer in the overall market: it outperformed 45.96% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to ALGN. ALGN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
On February 4, 2026 ALGN reported an EPS of 3.29 and a revenue of 1.05B. The company beat EPS expectations (8.54% surprise) and missed revenue expectations (-0.61% surprise).
24 analysts have analysed ALGN and the average price target is 205.76 USD. This implies a price increase of 25.29% is expected in the next year compared to the current price of 164.23.
For the next year, analysts expect an EPS growth of 9.37% and a revenue growth 4.12% for ALGN
Over the last trailing twelve months ALGN reported a non-GAAP Earnings per Share(EPS) of 10.52. The EPS increased by 12.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.17% | ||
| ROA | 6.58% | ||
| ROE | 10.13% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 27.78 | 53.953B | ||
| COO | COOPER COS INC/THE | 14.04 | 13.954B | ||
| SOLV | SOLVENTUM CORP | 10.16 | 11.471B | ||
| LNTH | LANTHEUS HOLDINGS INC | 14.78 | 5.196B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.92 | 4.051B | ||
| ICUI | ICU MEDICAL INC | 15.41 | 3.18B | ||
| HAE | HAEMONETICS CORP/MASS | 11.13 | 2.764B | ||
| XRAY | DENTSPLY SIRONA INC | 7.91 | 2.357B | ||
| NEOG | NEOGEN CORP | 26.49 | 2.034B | ||
| UFPT | UFP TECHNOLOGIES INC | 20.01 | 1.575B | ||
| STAA | STAAR SURGICAL CO | 130.25 | 914.719M | ||
| BVS | BIOVENTUS INC - A | 11.1 | 711.736M |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,290 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
IPO: 2001-01-26
ALIGN TECHNOLOGY INC
410 North Scottsdale Road, Suite 1300
Tempe ARIZONA 95134 US
CEO: Joseph M. Hogan
Employees: 20290
Phone: 18009279800
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. The company is headquartered in Tempe, Arizona and currently employs 20,290 full-time employees. The company went IPO on 2001-01-26. The firm provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The firm's non-case products include retention products, Invisalign training and adjusting tools. The company offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
The current stock price of ALGN is 164.23 USD. The price decreased by -1.61% in the last trading session.
ALGN does not pay a dividend.
ALGN has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
24 analysts have analysed ALGN and the average price target is 205.76 USD. This implies a price increase of 25.29% is expected in the next year compared to the current price of 164.23.
The Revenue of ALIGN TECHNOLOGY INC (ALGN) is expected to grow by 4.12% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
The outstanding short interest for ALIGN TECHNOLOGY INC (ALGN) is 3.53% of its float.